Conect4children: a new public-private partnership to improve the development of new drugs for children in Europe conect4children is a large collaborative paediatric network that will facilitate the development of new drugs and other therapies for the entire paediatric population in Europe.
The consortium heralds a novel collaboration between academic and private sectors that includes 33 academic and 10 industry partners from 20 European countries within the Innovative Medicine Initiative (IMI2).
The aim is to enhance the competitiveness of Europe as a critical region for developing medicines for children by using existing expertise, patient access and developing common processes to be applied to disease natural history studies, registries, studies of new therapies and comparisons of existing therapies.
SIOP Europe is co-leading Work Package 4 (Scientific advice, feasibility and innovation) with the leadership of Gilles Vassal (SIOPE past-President) who will represent the European paediatric oncology community in this project.
For further information, please access the SIOPE news release about conect4children: https://www.siope.eu/2018/05/22/conect4children-press-release 